FDA unit plans to issue guidance on combination products

09/26/2008 | FDAnews

The FDA's Office of Combination Products is set next week to release a draft guidance on the regulatory processes governing makers of imaging devices that use contrast agents or radiopharmaceuticals, Director Thinh Nguyen said. The OCP also plans to issue guidances for cross-labeling and auto-injectors.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Project Manager RA - 15000003MD
Santa Clara, CA
Director, Site Quality Management
Minneapolis, MN